Mice Model Market Size & Share 2023 to 2032

Report ID: GMI4473
   |
Published Date: May 2023
 | 
Report Format: PDF/Excel/Dashboard/Platform

Download Free PDF

Explore our licensing options:

Mice Model Market Size

Mice Model Market size exceeded USD 9.5 billion in 2022 and will depict over 6% CAGR from 2023 to 2032, driven by rising demand for humanized mice models.

 

Mice Model Market

The genetic resemblance between mice and humans is positively influencing market growth and boosting the demand for mouse models in biomedical research. The positive inclination of researchers toward the study of human diseases using mouse models as humans share more than 95% of their protein-coding and over 28% of non-coding sequences with mice genome, is set to provide lucrative opportunities to the market.

 

Despite a positive outlook for the mice model market, ongoing developments of alternative methods for animal testing will negatively influence product adoption. Researchers are compelled to find strategies to save time and employ fewer animals in drug screening procedures since millions of experimental animals are utilized each year globally. Scientists have therefore devised other methods that would reduce the number of mice employed as research subjects. Nonetheless, promising developments in the field would aid in overcoming this issue.

 

Mice Model Market Analysis

Global Mice Model Market Size, By Mice

In terms of mice, the inbred mice model market will reach over USD 4.5 billion by 2032. The growing adoption of inbred mice for studying the genetic bases of phenotypic variation and the rising use in cancer research for understanding the genetic basis of tumor development and cancer progression is bolstering segment development. For instance, inbred mice are commonly used to reproduce DIO models to reduce modeling time and attain stable metrics.
 

Global Mice Model Market Size, By Technology

The mice model market revenue size from the CRISPR technology segment will reach more than USD 6 billion by the end of 2032. This is attributed to its cost-effectiveness, time efficiency, and convenience compared to traditional gene editing techniques such as transcription activators-like effective nucleases (TALENS). Moreover, growing awareness regarding the advantages of CRISPR technology is promoting product demand. A 2022 study highlighted that 54 of 85 isolates of enterococci species indicated a presence of CRISPR-Cas loci, accounting for more than 63% of total samples.

 

North America Mice Model Market

Regionally, North America accounted for over 80% of the mice model market revenue in 2022, attributed to the high prevalence of chronic diseases including diabetes and viral diseases. As per a recent report, by 2060, people under age 20 with type 2 diabetes would increase by approximately 675% in the U.S. Moreover, several research organizations in the region are also focusing on developing effective therapeutic drugs for the treatment of viral diseases, which is increasing the demand for mice models.

 

Mice Model Market Share

Some of the key players profiled in the mice model market report include

  • Charles River Laboratories International Inc
  • Taconic Biosciences, Inc.
  • Janvier Labs
  • genOway
  • Hera Biolabs
  • TransViragen Inc.
  • The Jackson Laboratory
  • Inotiv
  • Allentown LLC
  • Harbour Biomed
  • PolyGene

These firms engage in promising acquisitions and mergers to propel their market position.

 

Mice Model Industry News

  • In September 2022, genOway, a biotechnology firm, expanded its partnership with Sigma-Aldrich, a science and tech subsidiary of Merck. With this, both companies agreed to continue collaborative R&D programs and innovations in CRISPR/Cas9 rodent model market and boost the CRISPR patent portfolio.
     
  • In October 2022, Taconic Biosciences, Inc., an animal model solutions provider, introduced the FcResolv NOG collection, a range of highly immunodeficient mice models missing residual murine Fc gamma receptors. The new portfolio is applicable in oncology, immune-oncology, and autoimmune diseases, to engraft multiple human cells and tissues.
     

The mice model market research report includes in-depth coverage of the industry with estimates & forecast in terms of revenue in USD Million from 2018 to 2032 for the following segments:

Market Size, By Mice

  • Inbred
  • Outbred
  • Knockout
  • Hybrid
  • Other Mice

Market Size, By Technology

  • CRISPR
  • Microinjection
  • Embryonic Stem Cell Injection
  • Nuclear Transfer
  • Other Technologies

Market Size, By Application

  • Research & Development
    • Infectious Disease
    • Immunological Diseases
    • Cancer
    • Cardiovascular Diseases
    • Diabetes
    • Genetic Diseases
    • Neurological Diseases
    • Other Diseases
  • Production and Quality Control
  • Academics
  • Other Applications

Market Size, By Use

  • Human
  • Veterinary

Market Size, By End-use

  • Companies
    • Pharmaceutical
    • Biotechnology
    • Cosmetics
    • Other Companies
  • Organisations
    • Government
    • Non-government
  • Academic and Research Institutes
  • Contract Research Organizations (CRO)

The above information is provided for the following regions and countries:

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • UK
    • France
    • Spain
    • Italy
    • Switzerland
    • Netherlands
    • Czech Republic
    • Poland
    • Belgium
    • Finland
    • Hungary
    • Denmark
    • Ireland
    • Sweden
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • Australia
    • South Korea
    • New Zealand
    • Taiwan
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Mexico
    • Argentina
    • Rest of Latin America
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE
    • Israel
    • Rest of Middle East & Africa

 

AuthorsMonali Tayade, Sampada Kulkarni
Mice Model Market Scope
  • Mice Model Market Size
  • Mice Model Market Trends
  • Mice Model Market Analysis
  • Mice Model Market Share

Report Content

Chapter 1   Methodology & Scope

1.1    Industry coverage

1.2    Market scope and definitions

1.3    Base estimates and working

1.3.1    Data collection

1.4    Forecast parameters

1.5    COVID-19 impact analysis at global level

1.6    Data validation

1.7    Data sources

1.7.1    Primary

1.7.2    Secondary

1.7.2.1   Paid sources

1.7.2.2   Unpaid sources

Chapter 2   Executive Summary

2.1    Mice model industry 3600 synopsis, 2018 - 2032

2.1.1    Business trends

2.1.2    Mice Type trends

2.1.3    Technology trends

2.1.4    Application trends

2.1.5    Use trends

2.1.6    End-use trends

2.1.7    Regional trends

Chapter 3   Mice Model Industry Insights

3.1    Industry segmentation

3.2    Industry landscape, 2018 – 2032

3.3    Industry impact forces

3.3.1    Growth drivers

3.3.1.1   Rise in the advancements in gene editing tools

3.3.1.2   Rising demand for humanized mice models

3.3.1.3   Physiological similarities between human and Mice

3.3.1.4   Growing consumption of personalized medicine in developing and developed countries

3.3.2    Industry pitfalls & challenges

3.3.2.1   Ongoing developments of alternative methods to animal testing

3.3.2.2   Strict regulations and guidelines

3.3.2.3   Growing opposition on mice testing by several organizations

3.4    Growth potential analysis

3.4.1    By mice type

3.4.2    By technology

3.4.3    By application

3.4.4    By use

3.4.5    By end-use

3.5    COVID-19 impact analysis

3.6    Technological advances in using mice models for studying ovarian cancer

3.7    Advantages and disadvantages of in vivo mouse models

3.8    Porter’s analysis

3.9    PESTEL analysis

Chapter 4   Competitive Landscape, 2022

4.1    Introduction

4.2    Company matrix analysis, 2022

4.3    Company positioning matrix

4.4    Competitive analysis of major market players

4.5    Strategic outlook matrix

4.6    Strategy dashboard, 2022

Chapter 5   Mice Model Market, By Mice Type

5.1    Key mice type trends

5.2    Inbred

5.2.1    Market estimates and forecast, 2018 - 2032 (USD Million)

5.2.2    Market estimates and forecast, 2018 - 2032 (000' Units)

5.3    Outbred

5.3.1    Market estimates and forecast, 2018 - 2032 (USD Million)

5.3.2    Market estimates and forecast, 2018 - 2032 (000' Units)

5.4    Knockout

5.4.1    Market estimates and forecast, 2018 - 2032 (USD Million)

5.4.2    Market estimates and forecast, 2018 - 2032 (000' Units)

5.5    Hybrid

5.5.1    Market estimates and forecast, 2018 - 2032 (USD Million)

5.5.2    Market estimates and forecast, 2018 - 2032 (000' Units)

5.6    Other mice types

5.6.1    Market estimates and forecast, 2018 - 2032 (USD Million)

5.6.2    Market estimates and forecast, 2018 - 2032 (000' Units)

Chapter 6   Mice Model Market, By Technology

6.1    Key technology trends

6.2    CRISPR

6.2.1    Market estimates and forecast, 2018 - 2032 (USD Million)

6.3    Microinjection

6.3.1    Market estimates and forecast, 2018 - 2032 (USD Million)

6.4    Embryonic stem cell injection

6.4.1    Market estimates and forecast, 2018 - 2032 (USD Million)

6.5    Nuclear transfer

6.5.1    Market estimates and forecast, 2018 - 2032 (USD Million)

6.6    Other technologies

6.6.1    Market estimates and forecast, 2018 - 2032 (USD Million)

Chapter 7   Mice Model Market, By Application

7.1    Key application trends

7.2    Research & development

7.2.1    Market estimates and forecast, 2018 - 2032 (USD Million)

7.2.2    Infectious diseases

7.2.2.1   Market estimates and forecast, 2018 - 2032 (USD Million)

7.2.3    Immunological diseases

7.2.3.1   Market estimates and forecast, 2018 - 2032 (USD Million)

7.2.4    Cancer

7.2.4.1   Market estimates and forecast, 2018 - 2032 (USD Million)

7.2.5    Cardiovascular diseases

7.2.5.1   Market estimates and forecast, 2018 - 2032 (USD Million)

7.2.6    Diabetes

7.2.6.1   Market estimates and forecast, 2018 - 2032 (USD Million)

7.2.7    Genetic diseases

7.2.7.1   Market estimates and forecast, 2018 - 2032 (USD Million)

7.2.8    Neurological diseases

7.2.8.1   Market estimates and forecast, 2018 - 2032 (USD Million)

7.2.9    Other diseases

7.2.9.1   Market estimates and forecast, 2018 - 2032 (USD Million)

7.3    Production and quality control

7.3.1    Market estimates and forecast, 2018 - 2032 (USD Million)

7.4    Academics

7.4.1    Market estimates and forecast, 2018 - 2032 (USD Million)

7.5    Other applications

7.5.1    Market estimates and forecast, 2018 - 2032 (USD Million)

Chapter 8   Mice Model Market, By Use

8.1    Key use trends

8.2    Human

8.2.1    Market estimates and forecast, 2018 - 2032 (USD Million)

8.3    Veterinary

8.3.1    Market estimates and forecast, 2018 - 2032 (USD Million)

Chapter 9   Mice Model Market, By End-use

9.1    Key end-use trends

9.2    Companies

9.2.1    Market estimates and forecast, 2018 - 2032 (USD Million)

9.2.2    Pharmaceutical

9.2.2.1   Market estimates and forecast, 2018 - 2032 (USD Million)

9.2.3    Biotechnology

9.2.3.1   Market estimates and forecast, 2018 - 2032 (USD Million)

9.2.4    Cosmetics

9.2.4.1   Market estimates and forecast, 2018 - 2032 (USD Million)

9.2.5    Other companies

9.2.5.1   Market estimates and forecast, 2018 - 2032 (USD Million)

9.3    Organisations

9.3.1    Market estimates and forecast, 2018 - 2032 (USD Million)

9.3.2    Government

9.3.2.1   Market estimates and forecast, 2018 - 2032 (USD Million)

9.3.3    Non-government

9.3.3.1   Market estimates and forecast, 2018 - 2032 (USD Million)

9.4    Academic and research institutes

9.4.1    Market estimates and forecast, 2018 - 2032 (USD Million)

9.5    Contract research organizations (CRO)

9.5.1    Market estimates and forecast, 2018 - 2032 (USD Million)

Chapter 10   Mice Model Market, By Region

10.1    Key regional trends

10.2    North America

10.2.1    U.S.

10.2.2    Canada

10.3    Europe

10.3.1    Germany

10.3.2    UK

10.3.3    France

10.3.4    Spain

10.3.5    Italy

10.3.6    Switzerland

10.3.7    Netherlands

10.3.8    Czech Republic

10.3.9    Poland

10.3.10    Belgium

10.3.11    Finland

10.3.12    Hungary

10.3.13    Denmark

10.3.14    Ireland

10.3.15    Sweden

10.3.16    Rest of Europe

10.4    Asia Pacific

10.4.1    China

10.4.2    Japan

10.4.3    Australia

10.4.4    South Korea

10.4.5    New Zealand

10.4.6    Taiwan

10.4.7    Rest of Asia Pacific

10.5    Latin America

10.5.1    Brazil

10.5.2    Mexico

10.5.3    Argentina

10.5.4    Rest of Latin America

10.6    Middle East & Africa

10.6.1    South Africa

10.6.2    Saudi Arabia

10.6.3    UAE

10.6.4    Israel

10.6.5    Rest of Middle East & Africa

Chapter 11   Company Profiles

Don't see your key competitors?

The companies listed in this report are a curated selection - not the full competitive universe.

Our market revenue calculations use a bottom-up methodology that accounts for all players across all regions - including manufacturers, distributors, and specialists not individually profiled. The profiles section spotlights strategically significant players; it does not define the scope of our market sizing.

Your competitive landscape may also include

Regional or domestic-only leaders not in the global top tier
Distributors and channel partners who control market access
Emerging disruptors, startups, or adjacent-industry entrants
Niche players focused on a specific application or end-use

Free customization - up to 20% of report value

Need specific data? Request customization and get the insights tailored to your exact requirements.

For inquiries regarding discounts, bulk purchases, or customization requests, please contact us at [email protected]